Medical investigation of children with autistic spectrum disorders

Child: Care, Health and Development

Volumn 32, Issue 5, 2006, Pages 521-533

  Cass, Hilary ^a   Sekaran, D ^b   Baird, G ^c  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Autistic spectrum; Disorders; Investigation protocols; Learning disability

Indexed keywords

ANTICONVULSIVE AGENT; LEAD;

ANAMNESIS; ANTICONVULSANT THERAPY; AUTISM; CHILD; CHROMOSOME 2Q; CHROMOSOME 7Q; CLINICAL FEATURE; CLINICAL PROTOCOL; COMORBIDITY; CYTOGENETICS; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTROENCEPHALOGRAM; EPILEPSY; FRAGILE X SYNDROME; GENETIC ANALYSIS; HEREDITY; HUMAN; INCIDENCE; KARYOTYPING; LEAD POISONING; LESCH NYHAN SYNDROME; MEDICAL EXAMINATION; METABOLIC DISORDER; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

ABNORMALITIES; AUTISTIC DISORDER; CHILD; CHROMOSOME DISORDERS; CLINICAL PROTOCOLS; CONGENITAL ABNORMALITIES; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; GENETIC DISEASES, INBORN; HUMANS; NERVOUS SYSTEM DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; TIME FACTORS;

EID: 33747068770     PISSN: 03051862     EISSN: 13652214     Source Type: Journal    
DOI: 10.1111/j.1365-2214.2006.00630.x     Document Type: Review

References (77)

1. Anderson, R. J., Bendell, D. J., Garnett, I., Groundwater, P. W., Lough, W. J., Mills, M. J., Savery, D. & Shattoch, P. E. (2002) Identification of indoly1-3-acryloylglycine in the urine of people with autism. J Pharm Pharmacol, 54, 295-298.
2. Aveyard, P. (1997) Evidence-based medicine and public health. Journal of Evaluation in Clinical Practice, 3, 139-144.
3. Bailey, D. B., Mesibov, G. B., Hatton, D. D., Clark, R. D., Roberts, J. E. & Mayhew, L. (1998) Autistic behavior in young boys with fragile X syndrome. Journal of Autism and Developmental Disorders, 28, 499-508.
4. Baird, G., Cass, H. & Slonims, V. (2003) Diagnosis of autism. British Medical Journal, 327, 494-497.
5. Baker, P., Piven, J. & Sato, Y. (1998) Autism and tuberous sclerosis complex: Prevalence and clinical features. Journal of Autism and Developmental Disorders, 28, 279-285.
6. Barton, M. & Volkmar, F. (1998) How commonly are known medical conditions associated with autism? Journal of Autism and Developmental Disorders, 28, 273-278.
7. Batholomeusz, H. H., Courchesne, E. & Karns, C. M. (2002) Relationship between head circumference and brain volume in healthy normal toddlers, children and adults. Neuropediatrics, 33, 239-241.
8. Bolton, P. F., Park, R. J., Higgins, J. N., Griffiths, P. D. & Pickles, A. (2002) Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain, 125, 1247-1255.
9. Bull, G., Shattock, P., Whiteley, P., Anderson, R., Groundwater, P. W., Lough, W. J. & Lees, G. (2003) Indolyl-3-acryloylglycine (IAG) is a putative diagnostic urinary marker for autism spectrum disorders. Medical Sciences Monitor 9, CR422-CR425.
10. Cass, H. (1998) Autism and severe visual impairment; current questions and future research. Autism: The International Journal of Research and Practice, 2, 117-138.
11. Chugani, D. C. (2004) Serotonin in autism and pediatric epilepsies. Mental Retardation and Developmental Disabilities Research Reviews, 10, 112-116.
12. Chugani, D. C., Muzik, O., Rothermel, R., Behen, M., Chakraboty, P., Mangner, T., da Silva, E. A. & Chugani, H. T. (1997) Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Annals of Neurology, 42, 666-669.
13. Cohen, D., Pichard, N., Tordjman, S., Baumann, C., Burglen, L., Excoffner, E., Lazar, G., Mazet, P., Pinquier, C., Verloes, A. & Heron, D. (2005) Specific genetic disorders and autism: Clinical contribution towards their identification. Journal of Autism and Developmental Disorders, 35, 103-115.
14. Cook, E. H. Jr (2001), Genetics of autism. Child and Adolescent Psychiatry. Clinics of North America, 10, 333-350.
15. Courchesne, E., Karns, C., Davis, H. R., Ziccardi R., Carper, R. A., Tigue, Z. D., Chisum, H. J., Moses, P., Pierce, K., Lord, C., Lincoln, A. J., Pizzo, S., Schreibman, L., Haas, R. H., Akshoomoff, N. A. & Courchesne, R. Y. (2001) Unusual brain growth patterns in early life in patients with autistic disorder: An MRI study. Neurology, 57, 245-254.
16. Courchesne, E., Carper, R. & Akshoomoff, N. (2003) Evidence of brain overgrowth in the first year of life in autism. Journal of the American Medical Association, 290, 337-344.
17. Dager, S. (2004) Longitudinal Brain Developmental Changes in Young Children with Autism. International Meeting for Autism Research, Sacramento, CA, 7 May 2004.
18. Eliaz, S. & Reiss, A. L. (2000) Annotation: MRI neuroimaging of childhood psychiatric disorders: A selective review. Journal of Child Psychology and Psychiatry, 41, 679-694.
19. Fernell, E., Gillberg, C. & von Wendt, L. (1991) Autistic symptoms in children with infantile hydrocephalus. Acta Paediatrica Scandinavica., 80, 451-457.
20. Filipek, P. A. (1999) Neuroimaging in the developmental disorders: The state of the science. Journal of Child Psychology and Psychiatry, 40, 113-128.
21. Filipek, P. A., Accardo, P. J., Baranek, G. T., Cook, E. H., Dawson, G., Gordon, B., Gravel, H., Johnson, C. P., Kallen, R. J., Levy, S. E., Minshew, N. J., Ozonoff, S., Prizant, B. M., Rapin, I., Rogers, S. J., Stone, W. L., Teplin, S. W., Tuchman, R. F. & Volkmar, F. R. (1999) The screening and diagnosis of autistic spectrum disorders. Journal of Autism and Developmental Disorders, 29, 439-484.
22. Filipek, P. A., Accardo, P. J., Ashwal, S., Baranek, G. T., Cook, E. H., Dawson, G., Gordon, B., Gravel, H., Johnson, C. P., Kallen, R. J., Levy, S. E., Minshew, N. J., Ozonoff, S., Prizant, B. M., Rapin, I., Rogers, S. J., Stone, W. L., Teplin, S. W., Tuchman, R. F., & Volkmar, F. R. (2000) Practice parameter: Screening and diagnosis of autism. Neurology, 55, 468-479.
23. Fisch, G. S. (1992) Is autism associated with the fragile X syndrome? American Journal of Medical Genetics, 43, 47-55.
24. Fombonne, E., Du Mazaubrun, C., Cans, C. & Grandjean, H. (1997) Autism and associated medical disorders in a French epidemiological survey. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1561-1569.
25. Giangreco, C. A., Steele, M. W., Aston, C. E., Cummins, J. H. & Wenger, S. L. (1996) A simplified six-item checklist for screening for fragile X syndrome in the pediatric population. J Pediatr, 129, 611-614.
26. Gillberg, C. (1992) Subgroups in autism: Are there behavioural phenotypes typical of underlying medical conditions? Journal of Intellectual Disability Research, 36, 201-214.
27. Gillberg, C. & Coleman, M. (1996) Autism and medical conditions: A review of the literature. Developmental Medicine and Child Neurology, 38, 191-202.
28. Goldberg, J., Szatmari, P. & Nahmias, C. (1999) Imaging of autism: lessons from the past to guide studies in the future. Canadian Journal of Psychiatry, 44, 793-801.
29. Goodman, N. W. (2005) Does the MMR jab cause autism? BMJ, 331 (7508), 111.
30. Gutierrez, G. C., Smalley, S. L. & Tanguay, P. E. (1998) Autism in tuberous sclerosis complex. Journal of Autism and Developmental Disorders, 28, 97-103.
31. Hagerman, R. J., Jackson, A. W., Levitas, A., Rimland, B. & Braden, M. (1986) An analysis of autism in fifty males with the fragile X syndrome. American Journal of Medical Genetics, 23, 359-374.
32. Hartley, L., Salt, A., Dorling, J. & Gringras, J. (2002) Investigation of children with "developmental delay". West J Med, 176, 29-33.
33. Holmes, G. L. & Ben-Ari, Y. (2001) The neurobiology and consequences of epilepsy in the developing brain. Pediatric Research, 49, 320-325.
34. Holmes, G. L., Chronopoulos, A., Stafstrom, C. E., Mikati, M. A., Thurber, S. J., Hyde, P. A. & Thompson, J. L. (1993) Effects of kindling on subsequent learning, memory, behaviour, and seizure susceptibility. Brain Research and Developmental Brain Research, 73, 71-77.
35. Hunt, A. & Shepherd, C. (1993) A prevalence study of autism in tuberous sclerosis. Journal of Autism and Developmental Disorders, 23, 323-339.
36. Hunter, L. C., O'Hare, A., Herron, W. J., Fisher, L. A. & Jones, G. E. (2003) Opioid peptides and dipeptidyl peptidase in autism. Developmental Medicine and Child Neurology, 45, 121-128.
37. Jambaque, I., Chiron, C., Dumas, C., Munford, J. & Dulac, O. (2000) Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients. Epilepsy Research, 38, 151-160.
38. Kent, L., Evans, J., Paul, M. & Sharp, M. (1999) Comorbidity of autistic spectrum disorders in children with Down syndrome. Developmental Medicine and Child Neurology, 41, 153-158.
39. Kielinen, M., Rantala, H., Timonen, E., Linna, S. & Moilanen, I. (2004) Associated medical disorders and disabilities in children with autistic disorder. Autism, 8, 49-60.
40. Kurita, H. (1985) Infantile autism with speech loss before the age of thirty months. Journal of the American Academy of Child Psychiatry, 24, 191-196.
41. LeCouteur, A. & Baird, G. (2003) National Initiative for Autism Screening and Assessment (NIASA). National Autism Plan for Children. National Autistic Society, London, UK. Available at: http://www.nas.org.uk/profess/niasa.html (accessed 5 May 2005).
42. Lewis, K. E., Lubetsky, M. J., Wenger, S. L. & Steele, M. W. (1995) Chromosomal abnormalities in a psychiatric population. American Journal of Medical Genetics, 60, 53-54.
43. Lewis, J. C., Thomas, H. V., Murphy, K. C. & Sampson, J. R. (2004) Genotype and psychological phenotype in tuberous sclerosis. Journal of Medical Genetics, 41, 203-207.
44. MacLean, J. E., Teshima, I. E., Szatmari, P. & Nowaczyk, M. J. (2000) Ring chromosome 22 and autism: Report and review. American Journal of Medical Genetics, 90, 382-385.
45. Mantovani, J. (2000) Autistic regression and Landau-Kleffner syndrome: progress or confusion. Developmental Medicine and Child Neurology, 42, 349-353.
46. Moulding, N. T., Silagy, C. A. & Weller, D. P. (1999) A framework for effective management of change in clinical practice. Quality in Health Care, 8, 177-183.
47. MRC Autism Review (2001) MRC Review of Autism Research: Epidemiology and Causes. Medical Research Council. Available at: http://www.mrc.ac.uk/pdf-autism-report.pdf (accessed 11 September 2005).
48. Nordin, V. & Gillberg, C. (1998) The long term course of autistic disorders: Up date on follow-up studies. Acta Psychiatrica Scandinavica, 97, 99-108.
49. Oliviera, G., Diogo, L., Grazina, M., Garcia, P., Ataide, A., Marques, C., Miguel, T., Borges, L., Vicente, A. M. & Oliviera, C. R. (2005) Mitochondrial dysfunction in autism spectrum disorders: A population-based study. Developmental Medicine and Child Neurology, 47, 185-189.
50. Olsson, I., Steffenburg, S. & Gillberg, C. (1998) Epilepsy in autism and autistic like conditions: A population based study. Archives of Neurology, 45, 666-668.
51. Pickles, A., Bolton, P., Macdonald, H., Bailey, D., Le Couteur, A., Sim, C. H. & Rutter, M. (1995) Latent-class analysis of recurrence risks for complex phenotypes with selection and measurement error: A twin and family history study of autism. American Journal of Human Genetics, 57, 717-726.
52. Piven, J. (2004) Longitudinal MRI Study of 18-35 Month Olds with Autism. International Meeting for Autism Research. Sacramento, CA. 7 May 2004.
53. Rapin, I. & Katzman, R. (1998) Neurobiology of autism. Annals of Neurology, 43, 7-13.
54. Reichelt, K. L., Knivsberg, A. M., Lind, G. & Nodland, M. (1991) Probable etiology and possible treatment of childhood autism. Brain Dysfunction, 4, 308-319.
55. Reichelt, K.-L., Knivsberg, A.-M., Nodland, M., & Lind, G. (1994). Nature and consequences of hyperpeptiduria and bovine casomorphins found in autistic syndromes. Developmental Brain Dysfunction, 7, 71-85.
56. Ridler, K., Bullmore, E. T., De Vries, P. J., Suckling, J., Barker, G. J., Meara, S. J., Williams, S. C. & Bolton, P. F. (2001) Widespread anatomical abnormalities of grey and white matter structure in tuberous sclerosis. Psychological Medicine, 31, 1437-1446.
57. Riikonen, R. & Simell, O. (1990) Tuberous sclerosis and infantile spasms. Dev Med Child Neurol, 32(3), 203-209.
58. Risch, N., Spiker, D., Lotspeich, L., Nouri, N., Hinds, D., Hallmayer, J., Kalaydjieva, L., McCague, P., Dimiceli, S., Pitts, T., Nguyen, L., Yang, J., Harper, C., Thorpe, D., Vermeer, S., Young, H., Hebert, J., Lin, A., Ferguson, J., Chiotti, C., Wiese-Slater, S., Rogers, T., Salmon, B., Nicholas, P. & Myers, R. M. (1999) A genomic screen of autism: Evidence for a multilocus etiology. American Journal of Human Genetics, 65, 493-507.
59. Ronen, G. M., Richards, J. E., Cunningham, C., Secord, M. & Rosenbloom, D. (2000) Can sodium valproate improve learning in children with epileptiform bursts but without clinical seizures? Developmental Medicine and Child Neurology, 42, 751-755.
60. Rossi, P. G., Parmeggiani, A., Bach, V., Santucci, M. & Visconti, P. (1995) EEG features and epilepsy in patients with autism. Brain and Development, 17, 169-174.
61. Sackett, D. L., Straus, S. E., Richardson, W. S., Rosenberg, W. & Hayners, R. B. (2000) Evidence-based Medicine: How to Practice and Teach EBM. Churchill Livingstone, London, UK.
62. Schroer, R. J., Phelan, M. C., Michaelis, R. C., Crawford, E. C., Skinner, S. A., Cuccaro, M., Simensen, R. J., Bishop, J., Skinner, C., Fender, D. & Stevenson R. E. (1998) Autism and maternally derived aberrations of chromosome 15q. Am J Med Genet, 76, 327-336.
63. Shattock, P., Kennedy, A., Rowell, F. & Berney, T. (1990) Role of neuropeptides in autism and their relationship with classical neurotransmitters. Brain Dysfunction, 3, 328-345.
64. Shekelle, P. G., Woolf, S., Eccles, M. & Grimshaw, J. (1999) Developing guidelines. British Medical Journal, 318, 593-596.
65. Shinnar, S., Rapin, I., Arnold, S., Tuchman, R., Shulman, L., Ballaban-Gil, K., Maw, M., Deuel. R. & Volkmar, F. (2001) Language regression in childhood. Pediatric Neurology, 24, 183-185.
66. Sidenvall, R., Forsgren, L., Blomquist. H. K. & Heijbel, J. (1993) A community based prospective incidence study of epileptic seizures in children Acta Paediatrica, 82, 60-65.
67. Simonoff, E. (1998) Genetic counselling in autism and pervasive developmental disorders. Journal of Autism and Developmental Disorders, 28, 447-456.
68. Skjeldal, O. H., Sonheim, E., Ganes, T., Jellum, E. & Bakke, S. (1998) Childhood autism: The need for physical investigations. Brain and Development, 20, 227-233.
69. Smalley, S. L. (1998) Autism and tuberous sclerosis. Journal of Autism and Developmental Disorders, 28, 407-14.
70. Sparks, B. F., Friedman, S. D., Shaw, D. W., Aylward, E. H., Echelard, D., Artru, A. A., Maravilla, K. R., Giedd, J. N., Munson, J., Dawson, G. & Dager, S. R. (2002) Brain structural abnormalities in young children with autism spectrum disorder. Neurology, 59, 184-192.
71. Tharp, B. (2004) Epileptic encephalopathies and their relationship to developmental disorders: Do spikes cause autism. Mental Retardation and Developmental Disabilities Research Reviews, 10, 132-134.
72. Tuchman, R. F. & Rapin, I. (1997) Regression in pervasive developmental disorders: Seizures and epileptiform electroencephalogram correlates. Pediatrics, 99, 560-566.
73. Tuchman, R. F., Rapin, I. & Shinnar, S. (1991) Autistic and dysphasic children. 1: Clinical characteristics. Pediatrics, 88, 1211-1218.
74. Veenstra-Vanderweele, J. & Cook, E. (2003) Genetics of childhood disorders: Autism. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 116-118.
75. Wassink, T. H., Brzustowicz, L. M., Bartlett, C. W. & Szatmari, P. (2004) The search for autism disease genes. Mental Retardation and Developmental Disabilities Research Reviews, 10, 272-283.
76. Woolf, S., Grol, R., Hutchinson, A., Eccles, M. & Grimshaw, J. (1999) Potential benefits, limitations and harms of clinical guidelines. British Medical Journal, 318, 527-530.
77. Wright, B., Brzozowski, A. M., Calvert, E., Farnworth, H., Goodall, D. M., Holbrook, I., Imrie, G., Jordan, J., Kelly, A., Miles, J., Smith, R. & Town, J. (2005) Is the presence of urinary indolyl-3-acryloylglycine associated with autism spectrum disorder? Developmental Medicine and Child Neurology, 47, 190-192.